MHB039A for Injection

DRUG3 trials

Sponsors

Minghui Pharmaceutical (Hangzhou) Ltd

Conditions

Advanced Breast CancerAdvanced Lung CancerAdvanced Malignant Solid Tumor

Phase 1

A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors

RecruitingNCT07126665

Minghui Pharmaceutical (Hangzhou) LtdAdvanced Malignant Solid Tumor

Start: 2025-09-18End: 2031-08-31Target: 116Updated: 2025-11-18

A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer

RecruitingNCT07229599

Minghui Pharmaceutical (Hangzhou) LtdAdvanced Lung Cancer

Start: 2025-05-09End: 2030-05-31Target: 300Updated: 2025-11-17

Phase 2

A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors

RecruitingNCT07130383

Minghui Pharmaceutical (Hangzhou) LtdAdvanced Breast Cancer, Advanced Malignant Solid Tumor

Start: 2025-09-30End: 2031-08-31Target: 210Updated: 2025-11-18